{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:34:18Z","timestamp":1778283258223,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The work was supported by Intramural research grant to RNM."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s10067-018-4046-x","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T18:28:27Z","timestamp":1520447307000},"page":"1265-1271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Serum BAFF in Indian patients with IIM: a retrospective study reveals novel clinico-phenotypic associations in children and adults"],"prefix":"10.1007","volume":"37","author":[{"given":"Latika","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smriti","family":"Chaurasia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puja","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Able","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramnath","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"4046_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/rheumatology\/41.1.22","volume":"41","author":"SM Sultan","year":"2002","unstructured":"Sultan SM, Ioannou Y, Moss K, Isenberg DA (2002) Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality. Rheumatology (Oxford) 41:22\u201326","journal-title":"Rheumatology (Oxford)"},{"key":"4046_CR2","first-page":"S109","volume":"26","author":"IE Lundberg","year":"2008","unstructured":"Lundberg IE, Forbess CJ (2008) Mortality in idiopathic inflammatory myopathies. Clin Exp Rheumatol 26:S109\u2013S114","journal-title":"Clin Exp Rheumatol"},{"key":"4046_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/joim.12524","volume":"280","author":"IE Lundberg","year":"2016","unstructured":"Lundberg IE, Miller FW, Tj\u00e4rnlund A, Bottai M (2016) Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med 280:39\u201351","journal-title":"J Intern Med"},{"key":"4046_CR4","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/art.24411","volume":"60","author":"CM L\u00f3pez De Padilla","year":"2009","unstructured":"L\u00f3pez De Padilla CM, Vallejo AN, Lacomis D, McNallan K, Reed AM (2009) Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis. Arthritis Rheum 60:1160\u20131172","journal-title":"Arthritis Rheum"},{"key":"4046_CR5","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/mus.21739","volume":"42","author":"M Salajegheh","year":"2010","unstructured":"Salajegheh M, Pinkus JL, Amato AA, Morehouse C, Jallal B, Yao Y, Greenberg SA (2010) Permissive environment for B-cell maturation in myositis muscle in the absence of B-cell follicles. Muscle Nerve 42:576\u2013583","journal-title":"Muscle Nerve"},{"key":"4046_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/eji.201343315","volume":"44","author":"D McIntyre","year":"2014","unstructured":"McIntyre D, Zuckerman NS, Field M, Mehr R, Stott DI (2014) The V(H) repertoire and clonal diversification of B cells in inflammatory myopathies. Eur J Immunol 44:585\u2013596","journal-title":"Eur J Immunol"},{"key":"4046_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/art.37754","volume":"65","author":"CV Oddis","year":"2013","unstructured":"Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC, Barohn RJ, Feldman BM, Harris-Love MO, Koontz DC, Fertig N, Kelley SS, Pryber SL, Miller FW, Rockette HE, and the RIM Study Group (2013) Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial. Arthritis Rheum 65:314\u2013324","journal-title":"Arthritis Rheum"},{"key":"4046_CR8","doi-asserted-by":"publisher","first-page":"e0133702","DOI":"10.1371\/journal.pone.0133702","volume":"10","author":"Y Allenbach","year":"2015","unstructured":"Allenbach Y, Guiguet M, Rigolet A, Marie I, Hachulla E, Drouot L, Jouen F, Jacquot S, Mariampillai K, Musset L, Grenier P, Devilliers H, Hij A, Boyer O, Herson S, Benveniste O (2015) Efficacy of rituximab in refractory inflammatory myopathies associated with anti-synthetase auto-antibodies: an open-label, phase II trial. PLoS One 10:e0133702","journal-title":"PLoS One"},{"key":"4046_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/1759720X15586782","volume":"7","author":"SA Morais","year":"2015","unstructured":"Morais SA, Vilas-Boas A, Isenberg DA (2015) B-cell survival factors in autoimmune rheumatic disorders. Ther Adv Musculoskelet Dis 7:122\u2013151","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"4046_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/cei.13039","volume":"190","author":"G Ferraccioli","year":"2017","unstructured":"Ferraccioli G, Gremese E (2017) B cell activating factor (BAFF) and BAFF receptors: fakes and facts. Clin Exp Immunol 190:291\u2013292","journal-title":"Clin Exp Immunol"},{"key":"4046_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jneuroim.2012.04.006","volume":"249","author":"A Baek","year":"2012","unstructured":"Baek A, Park HJ, Na S-J, Shim DS, Moon J-S, Yang Y, Choi YC (2012) The expression of BAFF in the muscles of patients with dermatomyositis. J Neuroimmunol 249:96\u2013100","journal-title":"J Neuroimmunol"},{"key":"4046_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s13075-014-0454-8","volume":"16","author":"O Kry\u0161t\u016ffkov\u00e1","year":"2014","unstructured":"Kry\u0161t\u016ffkov\u00e1 O, Barbasso Helmers S, Venalis P, Malmstr\u00f6m V, Lindroos E, Vencovsk\u00fd J et al (2014) Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52\/anti-Ro60 autoantibodies. Arthritis Res Ther 16:454","journal-title":"Arthritis Res Ther"},{"key":"4046_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2217\/bmm.13.124","volume":"8","author":"Q-L Peng","year":"2014","unstructured":"Peng Q-L, Shu X-M, Wang D-X, Wang Y, Lu X, Wang G-C (2014) B-cell activating factor as a serological biomarker for polymyositis and dermatomyositis. Biomark Med 8:395\u2013403","journal-title":"Biomark Med"},{"key":"4046_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/joim.12451","volume":"280","author":"Z Betteridge","year":"2016","unstructured":"Betteridge Z, McHugh N (2016) Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. J Intern Med 280:8\u201323","journal-title":"J Intern Med"},{"key":"4046_CR15","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00296-016-3494-3","volume":"36","author":"P Srivastava","year":"2016","unstructured":"Srivastava P, Dwivedi S, Misra R (2016) Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis. Rheumatol Int 36:935\u2013943","journal-title":"Rheumatol Int"},{"key":"4046_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","volume":"43","author":"DA Isenberg","year":"2004","unstructured":"Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, Oddis C, Pilkington C, Plotz P, Scott D, Vencovsky J, Cooper R, Rider L, Miller F, International Myositis and Clinical Studies Group (IMACS) (2004) International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 43:49\u201354","journal-title":"Rheumatology (Oxford)"},{"key":"4046_CR17","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3899\/jrheum.140977","volume":"42","author":"N Kobayashi","year":"2015","unstructured":"Kobayashi N, Kobayashi I, Mori M, Sato S, Iwata N, Shigemura T, Agematsu K, Yokota S, Koike K (2015) Increased serum B cell activating factor and a proliferation-inducing ligand are associated with interstitial lung disease in patients with juvenile dermatomyositis. J Rheumatol 42:2412\u20132418","journal-title":"J Rheumatol"},{"key":"4046_CR18","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/ard.2008.095984","volume":"68","author":"A Tournadre","year":"2009","unstructured":"Tournadre A, Miossec P (2009) Chemokines and dendritic cells in inflammatory myopathies. Ann Rheum Dis 68:300\u2013304","journal-title":"Ann Rheum Dis"},{"key":"4046_CR19","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/art.27465","volume":"62","author":"A Tournadre","year":"2010","unstructured":"Tournadre A, Lenief V, Miossec P (2010) Expression of toll-like receptor 3 and toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and Th17 cytokines. Arthritis Rheum 62:2144\u20132151","journal-title":"Arthritis Rheum"},{"key":"4046_CR20","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1136\/ard.2006.052191","volume":"65","author":"GJD Hengstman","year":"2006","unstructured":"Hengstman GJD, ter Laak HJ, Vree Egberts WTM, Lundberg IE, Moutsopoulos HM, Vencovsky J, Doria A, Mosca M, van Venrooij WJ, van Engelen BGM (2006) Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy. Ann Rheum Dis 65:1635\u20131638","journal-title":"Ann Rheum Dis"},{"key":"4046_CR21","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.ajpath.2012.08.033","volume":"181","author":"C Preu\u00dfe","year":"2012","unstructured":"Preu\u00dfe C, Goebel HH, Held J, Wengert O, Scheibe F, Irlbacher K, Koch A, Heppner FL, Stenzel W (2012) Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile. Am J Pathol 181:2161\u20132171","journal-title":"Am J Pathol"},{"key":"4046_CR22","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1136\/ard.2004.032359","volume":"64","author":"G Chevrel","year":"2005","unstructured":"Chevrel G, Granet C, Miossec P (2005) Contribution of tumour necrosis factor alpha and interleukin (IL) 1beta to IL6 production, NF-kappa B nuclear translocation, and class I MHC expression in muscle cells: in vitro regulation with specific cytokine inhibitors. Ann Rheum Dis 64:1257\u20131262","journal-title":"Ann Rheum Dis"},{"key":"4046_CR23","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bbamcr.2012.01.001","volume":"1823","author":"J Koci\u0107","year":"2012","unstructured":"Koci\u0107 J, Santiba\u00f1ez JF, Krsti\u0107 A, Mojsilovi\u0107 S, Dor\u0111evi\u0107 IO, Trivanovi\u0107 D et al (2012) Interleukin 17 inhibits myogenic and promotes osteogenic differentiation of C2C12 myoblasts by activating ERK1,2. Biochim Biophys Acta 1823:838\u2013849","journal-title":"Biochim Biophys Acta"},{"key":"4046_CR24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.biocel.2012.11.010","volume":"45","author":"J Koci\u0107","year":"2013","unstructured":"Koci\u0107 J, Santiba\u00f1ez JF, Krsti\u0107 A, Mojsilovi\u0107 S, Ili\u0107 V, Bugarski D (2013) Interleukin-17 modulates myoblast cell migration by inhibiting urokinase type plasminogen activator expression through p38 mitogen-activated protein kinase. Int J Biochem Cell Biol 45:464\u2013475","journal-title":"Int J Biochem Cell Biol"},{"key":"4046_CR25","doi-asserted-by":"crossref","unstructured":"Moura RA, Quaresma C, Vieira AR, Gon\u00e7alves MJ, Polido-Pereira J, Rom\u00e3o VC et al B-cell phenotype and IgD-CD27-memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis. PloS One 12:e0182927","DOI":"10.1371\/journal.pone.0182927"},{"key":"4046_CR26","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1136\/ard.2008.091405","volume":"68","author":"O Krystufkov\u00e1","year":"2009","unstructured":"Krystufkov\u00e1 O, Vallerskog T, Helmers SB, Mann H, Putov\u00e1 I, Bel\u00e1cek J et al (2009) Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies. Ann Rheum Dis 68:836\u2013843","journal-title":"Ann Rheum Dis"},{"key":"4046_CR27","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/art.21526","volume":"54","author":"T Matsushita","year":"2006","unstructured":"Matsushita T, Hasegawa M, Yanaba K, Kodera M, Takehara K, Sato S (2006) Elevated serum BAFF levels in patients with systemic sclerosis: enhanced BAFF signaling in systemic sclerosis B lymphocytes. Arthritis Rheum 54:192\u2013201","journal-title":"Arthritis Rheum"},{"key":"4046_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4103\/0973-3698.219083","volume":"12","author":"L Gupta","year":"2017","unstructured":"Gupta L, Ahmed S, Zanwar A (2017) The pathogenesis of scleroderma. Indian J Rheumatol 12:142","journal-title":"Indian J Rheumatol"},{"key":"4046_CR29","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1089\/thy.2015.0029","volume":"25","author":"I Campi","year":"2015","unstructured":"Campi I, Tosi D, Rossi S, Vannucchi G, Covelli D, Colombo F et al. (2015) B cell activating factor (BAFF) and BAFF receptor expression in autoimmune and nonautoimmune thyroid diseases. Thyroid Off J Am Thyroid Assoc 25:1043\u20131049","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"4046_CR30","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3899\/jrheum.120555","volume":"40","author":"CM L\u00f3pez De Padilla","year":"2013","unstructured":"L\u00f3pez De Padilla CM, McNallan KT, Crowson CS, Bilgic H, Bram RJ, Hein MS et al (2013) BAFF expression correlates with idiopathic inflammatory myopathy disease activity measures and autoantibodies. J Rheumatol 40:294\u2013302","journal-title":"J Rheumatol"},{"key":"4046_CR31","doi-asserted-by":"crossref","unstructured":"Bassyouni IH, Azab NA, El-Dakrony E-HM, Fawzi MMT, Ghanoum R, Bassyouni RH. Elevated serum levels of a proliferation-inducing ligand in patients with systemic sclerosis: possible association with myositis? Jt Bone Spine Rev Rhum 2011;78:56\u201361","DOI":"10.1016\/j.jbspin.2010.05.004"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-018-4046-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4046-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-018-4046-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T20:56:25Z","timestamp":1719867385000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-018-4046-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["4046"],"URL":"https:\/\/doi.org\/10.1007\/s10067-018-4046-x","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,7]]},"assertion":[{"value":"18 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}